Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HCK as a therapeutic target in MYD88 mutated diseases

HCK as a therapeutic target in MYD88 mutated diseases

US Patent 10525060 · Granted Jan 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

USP7 inhibition2025
Prefabricated laminated slab made in accordance with pretensioning fibermesh ant2025
Pseudo-boehmite, manufacturing process and application thereof2025
Load management for an electrical panel2025
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 2025
Potent and selective azaindole inhibitors of CDK8 and CDK192025
Bicyclic urea kinase inhibitors and uses thereof2025
Silica-alumina material containing lamellar structure, its preparation and appli2025
Allosteric EGFR inhibitors and methods of use thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Small molecule inhibitors of SRC tyrosine kinase2025
Degraders that target proteins via KEAP12025